Visiongain, a independent media company, issued the following news release:. Visiongain's new report Pharmaceutical Packaging Market Report 2017-2027: Global Forecasts by Material, Product Delivery System and Geography indicates that the pharmaceutical packaging market will see over $89.5 bn in revenue in 2017.. The lead analyst of the report said:
Renub Research report titled " China In-Vitro Diagnostics Market, By Diagnostics, Companies" provides a complete analysis of China In-Vitro Diagnostics Market. The market for China In-Vitro Diagnostics is likely to exceed US$ 12 Billion by the end of year 2024.. In Vitro Diagnostics- Devices and Reagents.
Doug Ducey, R- Arizona, issued the following news release:. Governor Doug Ducey today joined Walgreens to highlight the expansion of safe medication disposal kiosks across Arizona, aiding the state's fight against prescription drug and opioid abuse. Walgreens developed safe medication disposal kiosks to provide a convenient and secure way to dispos
On April 19, 2018 we announced that we have partnered with NxGen Brands, LLC; a company specializing in the sales and marketing of innovative healthcare products and service solutions, to market and distribute Nyloxin through their various distribution platforms. JAH Neal Holdings LLC will act as the minority Joint Venture partner with a 49% sta
-Synergy CHC Corp., a consumer health care& beauty company, today announced its first expansion into the Mexican marketplace. FOCUSfactor is sold at Americas leading retailers such as Costco, Sams Club, Wal-Mart, BJs, Walgreens, CVS and The Vitamin Shoppe. FOCUSfactor, Americas leading brain health supplement, is a nutritional supplement that inclu
Aug. 17 Colby Patterson's seizures started when he was playing Candy Land. Within a moment, he was right back in it and moved his piece past Candy Cane Forest. But now a new drug, Epidiolex, recently approved by the Food and Drug Administration, gives him hope the seizures can get under control, or even stop.
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases, has entered into a clinical research collaboration with AbbVie, a research-based global biopharmaceutical company, exploring the potential of combination therapy with AbbVie's venetoclax and Tolero's...
"China In Vitro Diagnostics Market is projected to exceed US$ 12 Billion by the end of year 2024." Renub Research report titled China In Vitro Diagnostics Market, By Diagnostics, Companies provides a complete analysis of China In Vitro Diagnostics Market. The report China In-Vitro Diagnostics Market, by Diagnostics, Companies "provid
Elite Pharmaceuticals Inc, a pharmaceutical group that develops abuse-deterrent opioids and niche generic drugs, has unveiled positive top-line results from key bio-equivalence studies conducted for an undisclosed antibiotic generic drug now being co-developed with SunGen Pharma. Based in Northvale, New Jersey, Elite Pharmaceuticals bills itself as
Monday evenings at 63 Jefferson Ave., Salem; and from noon to 1:30 p.m. Fridays at 75 Lindall St., Danvers. The Beverly and Addison Gilbert Hospital's Speakers Bureau is a free service designed to bring timely information on a variety of health-related topics. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors' conference room at
The global insomnia treatment drugs market was valued at US$ 2,689.6 Mn in 2017, and is expected to reach US$ 4,332.4 Mn by 2026, expanding at a CAGR of 5.5% from 2018 to 2026.. The latest market report published by Credence Research, Inc. "Global Insomnia Treatment Drugs Market- Growth, Future Prospects, Competitive Analysis, 2018- 2026," the glob
WiseGuyReports.Com Publish a New Market Research Report On- "Over-the-Counter Drug- Industry Trends, Sales, Supply, Demand, Analysis& Forecast to 2020". The analysts forecast the global over-the-counter drug market to grow at a CAGR of 6.19% during the period 2016-2020.. OTC drugs are medicines that can be bought without a prescription from a docto
"Over-the-Counter Drug Market" WiseGuyReports.Com Publish a New Market Research Report On Over-the-Counter Drug- Industry Trends, Sales, Supply, Demand, Analysis& Forecast to 2020.. OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. The
Theratechnologies Inc. is pleased to announce that results from the phase III clinical trial used to obtain FDA approval for Trogarzo? injection in the United States were published in the most recent edition of The New England Journal of Medicine. 1. Furthermore, the NEJM published an article, authored by the Office of the Antimicrobial Product
Visiongain, a independent media company, issued the following news release:. Visiongain has launched a new pharma report Anti- Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others. Leading companies featured in the report include Bayer AG,..
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and six months ended June 30, 2018.. The Company reported a net loss of $2.8 million or $0.13 per diluted share for the six months ended June 30, 2018, compared to a net loss of $1.7 million or $0.15 pe
This discussion and analysis should be read in conjunction with the Company's financial statements and accompanying notes included elsewhere in this Report. Historical operating results are not necessarily indicative of results in future periods. Finance LLC, or to obtain a waiver from Oxford Finance LLC for our failure to.
-Adherium, a leading digital health platform that focuses on improving medication adherence and patient outcomes, today officially launched the Hailie solution in the U.S., following its recent Food and Drug Administration 510 over-the-counter clearance to enable sales direct to consumers. Adherium believes health technology should be simple to use
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced second quarter 2018 financial results and Company update. New supplies of Vaprisol replenished nationwide supply of that critical care product designed to treat hyponatremia the m
Innovus Pharmaceuticals, Inc., today reported results for the second quarter 2018.. Revenues of $7.3 million, up 259% year-over-year and 61% from prior quarter. Gross margin remains consistent at 81% from prior quarter. Net loss remains consistent at $1.8 million from prior quarter even with significant investment in marketing and 61% increase in n
Innovus Pharmaceuticals, Inc., together with its subsidiaries, are collectively referred to as "Innovus", the "Company", "us", "we", or "our". The following information should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this report. For additional context with which to underst
The introduction of MinION, a portable and affordable sequencer by Nanopore Technologies, catering to users in point-of-care facilities and small peripheral laboratories, is expected to boost the growth of global molecular diagnostics market. According to WHO, the average prevalence rate of hospital-acquired infections in Europe and the U.S. was va
You should read this section in conjunction with our unaudited interim consolidated financial statements and related notes included in Part I. Item 1 of this Form 10- Q and our audited consolidated financial statements and related notes thereto and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in o
The unprecedented consensus statement from four national hearing care professional organizations recommends the new FDA classification be called "Self-fit OTC hearing devices." The paper recommends the new class be intended for mild-to-moderate hearing losses of 26-55 dB HL (26 max HFA-FOG/110 dB max output), offer input compression and volume cont
Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995,